- By conducting simultaneous clinical trials in patients and labs, Dana-Farber researchers and colleagues have been able to predict how patients with non-small cell lung cancer respond to combination therapy.
Tags: LungCancer, TranslationalResearch
- Charles Fuchs, MD, MPH, director of the Center for Gastrointestinal Oncology at Dana-Farber Cancer Institute, said colorectal cancer can be detected early thanks to one simple screening test, a colonoscopy.
Tags: ColonCancer, Prevention
- In a paper published online yesterday by the journal Nature, Dana-Farber researchers map out a mechanism by which micronuclei could potentially disrupt the chromosomes within them and produce cancer-causing gene mutations. The findings may point to a vulnerability in cancer cells that could be attacked by new therapies.
Tags: BasicResearch, Genomics
- The SU2C program, which will feature performances from top recording artists, and celebrities from film, television and sports, will encourage viewers to provide financial support for translational research aimed at accelerating the delivery of new cancer therapies to patients.
Tags: BasicResearch, Grants
- Researchers discover certain cells change roles to promote growth and
survival of malignant myeloma cancer cells. Encouragingly, it appears
possible to awaken them to their proper duty.
- "Twinning" U.S.-based and Rwandan physicians in a team approach has shown to improve lymphoma outcomes in children in a country lacking any specialists in children's cancers.
Tags: BasicResearch, ChildhoodCancer, Lymphoma
- A new study by researchers at Dana-Farber shows a small molecule compound called JQ1 can generate reversible birth control in male mice.
- The American College of Obstetricians and Gynecologists released new
guidelines saying women do not need their first Pap test until they're
21 years old.
- Adding Avastin to standard chemotherapy treatment may not improve survival rates for people with non-small cell lung cancer aged 65 plus, according to Dana-Farber researchers, who further suggest that clinicians exercise caution in including the drug in treatment recommendations.
Tags: chemotherapy, LungCancer
- In a nationwide study of women with triple-negative breast cancer, adding the chemotherapy drug carboplatin or the angiogenesis inhibitor Avastin to standard chemotherapy drugs brought a sharp increase in the number of patients whose tumors shrank away completely.
Tags: chemotherapy, BreastCancer
Showing 1-10 of 519 items